Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank79
3Y CAGR-4.2%
5Y CAGR+14.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-4.2%/yr
vs +26.2%/yr prior
5Y CAGR
+14.2%/yr
Recent deceleration
Acceleration
-30.3pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $141.49M | -19.2% |
| 2024 | $175.02M | +3.1% |
| 2023 | $169.82M | +5.6% |
| 2022 | $160.85M | +29.6% |
| 2021 | $124.12M | +70.5% |
| 2020 | $72.80M | -3.6% |
| 2019 | $75.49M | +18.9% |
| 2018 | $63.49M | +7.4% |
| 2017 | $59.12M | +23.7% |
| 2016 | $47.79M | - |